Danaher Corporation $DHR Stock Sold by Legacy Private Trust Co.

Legacy Private Trust Co. cut its position in shares of Danaher Corporation (NYSE:DHR) by 16.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,285 shares of the conglomerate’s stock after selling 2,456 shares during the quarter. Legacy Private Trust Co.’s holdings in Danaher were worth $2,722,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of DHR. Main Street Group LTD purchased a new stake in shares of Danaher during the 1st quarter worth about $25,000. N.E.W. Advisory Services LLC purchased a new position in Danaher in the second quarter valued at approximately $25,000. Hilton Head Capital Partners LLC acquired a new position in Danaher during the fourth quarter valued at approximately $27,000. Clal Insurance Enterprises Holdings Ltd lifted its position in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares in the last quarter. Finally, Evolution Wealth Management Inc. grew its stake in Danaher by 208.0% during the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock worth $29,000 after buying an additional 104 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Down 1.5%

DHR stock traded down $3.22 during trading on Tuesday, reaching $217.99. The stock had a trading volume of 1,795,986 shares, compared to its average volume of 4,452,666. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $153.25 billion, a P/E ratio of 38.71, a PEG ratio of 2.67 and a beta of 0.76. The firm has a fifty day moving average price of $209.69 and a 200 day moving average price of $193.88.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period last year, the firm earned $0.77 earnings per share. The company’s revenue was up 5.5% on a year-over-year basis. On average, equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is 28.42%.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. UBS Group assumed coverage on shares of Danaher in a research note on Wednesday, September 9th. They issued a “buy” rating and a $250.00 target price on the stock. Wells Fargo & Company decreased their price target on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Evercore reissued an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. TD Cowen reduced their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Finally, Royal Bank Of Canada increased their target price on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research note on Monday. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $234.09.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.